Comparison of dimethyl fumarate and interferon outcomes in an MS cohort

Comparison of dimethyl fumarate and interferon outcomes in an MS cohort

Abstract Background To compare the effectiveness of dimethyl fumarate (DMF) with subcutaneous interferon beta-1a (IFNβ-1a) in controlling disease activity in patients with relapsing–remitting Multiple Sclerosis (MS). Methods Clinical and imaging data from patients treated with either IFNβ-1a or DMF...

Full description

Bibliographic Details
Main Authors: Neda Sattarnezhad, Brian C. Healy, Moogeh Baharnoori, Camilo Diaz-Cruz, James Stankiewicz, Howard L. Weiner, Tanuja Chitnis
Format: Article
Language:English
Published: BMC 2022-07-01
Series:BMC Neurology
Subjects:
Multiple sclerosis
Dimethyl fumarate
Interferon
Disease activity
Effectiveness
Cohort
Online Access:https://doi.org/10.1186/s12883-022-02761-8

Internet

https://doi.org/10.1186/s12883-022-02761-8

Similar Items